Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes

Abstract Background Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment bef...

Full description

Bibliographic Details
Main Authors: Zhao Namula, Maki Hirata, Quynh Anh Le, Qingyi Lin, Koki Takebayashi, Naoaki Yoshimura, Fuminori Tanihara, Chommanart Thongkittidilok, Takeshige Otoi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Veterinary Medicine and Science
Subjects:
Online Access:https://doi.org/10.1002/vms3.659
_version_ 1819243195171602432
author Zhao Namula
Maki Hirata
Quynh Anh Le
Qingyi Lin
Koki Takebayashi
Naoaki Yoshimura
Fuminori Tanihara
Chommanart Thongkittidilok
Takeshige Otoi
author_facet Zhao Namula
Maki Hirata
Quynh Anh Le
Qingyi Lin
Koki Takebayashi
Naoaki Yoshimura
Fuminori Tanihara
Chommanart Thongkittidilok
Takeshige Otoi
author_sort Zhao Namula
collection DOAJ
description Abstract Background Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. Methods The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. Results The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. Conclusions Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate.
first_indexed 2024-12-23T14:51:50Z
format Article
id doaj.art-09413eb19a4b49469c97a4af02007d69
institution Directory Open Access Journal
issn 2053-1095
language English
last_indexed 2024-12-23T14:51:50Z
publishDate 2022-01-01
publisher Wiley
record_format Article
series Veterinary Medicine and Science
spelling doaj.art-09413eb19a4b49469c97a4af02007d692022-12-21T17:42:54ZengWileyVeterinary Medicine and Science2053-10952022-01-018116416910.1002/vms3.659Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotesZhao Namula0Maki Hirata1Quynh Anh Le2Qingyi Lin3Koki Takebayashi4Naoaki Yoshimura5Fuminori Tanihara6Chommanart Thongkittidilok7Takeshige Otoi8Faculty of Veterinary Science Guangdong Ocean University Zhanjiang ChinaFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanAkkhraratchakumari Veterinary College Walailak University Nakorn Sri Thammarat ThailandFaculty of Bioscience and Bioindustry Tokushima University Tokushima JapanAbstract Background Increasing the permeability of the zona pellucida (ZP) of oocytes before CRISPR/Cas9 electroporation may improve the efficiency of gene editing; however, the effects of this approach on subsequent developmental processes are unclear. In this study, the effects of ZP treatment before electroporation on embryonic development and gene editing in porcine embryos were evaluated. Methods The ZP of zygotes was weakened or removed by exposure to 0.5% actinase E, followed by electroporation of the Cas9 protein with guide RNA targeting GGTA1. Results The blastocyst formation rate of ZP‐free zygotes after electroporation was significantly lower (p < 0.05) than that of ZP‐intact zygotes. The mutation rate in blastocysts from ZP‐weakened zygotes was similar to that in ZP‐intact zygotes, whereas ZP removal increased the mutation rate. The mutation efficiency in blastocysts from electroporated zygotes did not differ among ZP treatment groups. Conclusions Our results indicate that weakening the ZP does not affect the developmental competence, mutation rate, or mutation efficiency of electroporated zygotes, whereas ZP removal has a detrimental effect on embryonic development but may increase the mutation rate.https://doi.org/10.1002/vms3.659CRISPRelectroporationgenome editingporcine zygotezona pellucida
spellingShingle Zhao Namula
Maki Hirata
Quynh Anh Le
Qingyi Lin
Koki Takebayashi
Naoaki Yoshimura
Fuminori Tanihara
Chommanart Thongkittidilok
Takeshige Otoi
Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
Veterinary Medicine and Science
CRISPR
electroporation
genome editing
porcine zygote
zona pellucida
title Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_full Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_fullStr Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_full_unstemmed Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_short Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
title_sort zona pellucida treatment before crispr cas9 mediated genome editing of porcine zygotes
topic CRISPR
electroporation
genome editing
porcine zygote
zona pellucida
url https://doi.org/10.1002/vms3.659
work_keys_str_mv AT zhaonamula zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT makihirata zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT quynhanhle zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT qingyilin zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT kokitakebayashi zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT naoakiyoshimura zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT fuminoritanihara zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT chommanartthongkittidilok zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes
AT takeshigeotoi zonapellucidatreatmentbeforecrisprcas9mediatedgenomeeditingofporcinezygotes